Regeneron

Regeneron Pharmaceuticals will make its newly approved gene therapy for a rare, genetic form of hearing loss…
Read More...

Rep. James Comer, R-Ky., on 23andMe data privacy concerns, his invitation for sanctuary governors to testify…
Read More...

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million USD…
Read More...